SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001393825-22-000099
Filing Date
2022-02-04
Accepted
2022-02-04 16:03:14
Documents
1

Document Format Files

Seq Description Document Type Size
1 CYCC 13G/A cycc_13ga.htm SC 13G/A 54236
  Complete submission text file 0001393825-22-000099.txt   55992
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Subject) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-80136 | Film No.: 22593216
SIC: 2834 Pharmaceutical Preparations

Mailing Address 28 HAVEMEYER PLACE 2ND FLOOR GREENWICH CT 06830
Business Address 28 HAVEMEYER PLACE 2ND FLOOR GREENWICH CT 06830 203-718-5690
Hudson Bay Capital Management LP (Filed by) CIK: 0001393825 (see all company filings)

IRS No.: 371511173 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A